Live News EQUITY FLASH M impact Nov 19, 2026, 09:10 AM UTC Guangzhou Innogen Subsidiary Licenses Efsubaglutide Alfa to Arcera The licensing deal is potentially worth over US$1 billion. SquawkNews Desk